HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Featured Stories


Bayer's Consumer Health Struggles Continue In Q1, But The Firm Insists It's On The Right Track

Bayer Consumer Health's sales declined at a single-digit rate in the first quarter of 2019, as the business continued to battle challenges in Europe and the US. Undeterred by this slow start to the year, the German firm says Consumer Health's performance will begin to turnaround in the coming months. 
Sales & Earnings Business Strategies OTC Drugs

'Mock' Recalls Suggested, But US FDA Isn't Joking About Recalling Products

FDA's suggestions in voluntary recalls draft guidance largely track with advice attorneys long have offered consumer health product firms. Instead, on top of November guidance on mandatory recall authority and February guidance on recall public notifications, FDA is making clear its expectations for firms' preparedness for recalls and their responses when faced with removing products from store shelves.

Regulation Recalls FDA

Fragrance Creators Association Racing To Amend Fast-Moving Disclosure Bill In California

The trade association opposes the proposed Cosmetic Fragrance and Flavor Ingredient Right to Know Act, which advanced out of California’s Senate Health Committee April 10, but the group’s position could change if key amendments are made to the bill. Fragrance Creators’ flexibility reflects political realities in California that could make it very difficult to defeat or delay the legislation.

Beauty Legislation Cosmetics

FDA Proposes Priorities For Cosmetic Ingredient Review: Mica, Probiotics, CBD

Nakissa Sadrieh, director of cosmetics at FDA and the agency’s CIR liaison, floated the three potential review priorities at the CIR Expert Panel’s April 8-9 meeting in Washington. It’s the most for-cause targets proposed by the agency in recent memory, and CIR leadership noted that they pose considerable challenges.

Beauty Cosmetic Ingredients Consumer
Advertisement

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

 

The 2019 OTC Marketing Awards

Co-presented by IRI – The 2019 OTC Marketing Awards celebrated the best and brightest of the UK consumer healthcare sector and clearly demonstrated that the industry is in rude health. Read this eBook to learn more.

Read more
Advertisement

Health Explore this Topic

Set Alert for Health

Latest From Health

France Warns Of Serious Complications Related To OTC Ibuprofen Use

French medicines regulator ANSM warns that use of certain OTC NSAIDs increases the risk of serious complications when suffering from a minor infection. The agency is advising consumers not to use iburofen or ketoprofen to treat pain or fever, and to instead opt for paracetamol. 
Drug Safety France

Benzoyl Peroxide Effective On Acne, But No Skin Microbiome Effect – Study

Acne treatment study found set out to better understand the pathogenesis of pre-adolescent acne and the impact of OTC acne drug benzoyl peroxide after an earlier study showed treatment with ingredient significantly decreased alpha diversity on girls' skin.

OTC Drugs Cosmetics

People Round-Up: Appointments At Afipa, J&J, Stada, WSMI, And Karo

J&J Consumer has a new chairman, Stada UK gets a permanent head, and Karo names its next CEO. On the association front, France's Afipa and the WSMI elect new leaders.
Appointments International

P&G Ups Forecast On Beauty, Health Results, Despite 'A Lot Of Variability'

P&G beauty division's sales grow on premium skin care lines and despite price increases as health care sales grow 5% on volume, particularly in oral care. Net earnings in latest quarter grow 9% to $2.78bn as results prompt investor activity with share price slipping 2.7% in trading at nearly twice average volume.

Commercial Business Strategies

OTC Private Labeler RIJ Pharmaceutical Must 'Fully Remediate' Water System

FDA asks RIJ Pharmaceutical, which recalled a dozen products last year, to provide plans for developing a solid water system design and mixing process. It warns private label manufacturer about contaminated, "‘super-potency" OTC drugs that resulted from GMP violations.

Health Advertising, Marketing & Sales

Health And Wellness Trademarks Review, April 16, 2019

Trademarks registered and published for opposition with USPTO in Class 3 – cosmetics and cleaning Preps, and Class 5 –pharmaceuticals. Marks for vitamin, mineral and supplement products also are registered or published for opposition in both Class 3 and Class 5.

OTC Drugs Dietary Supplements
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

FDA’s Cosmetics Manufacturing Survey Under Way; J&J, Colgate Jointly Defending Talc In California; News In Brief

FDA moves ahead with its plan to survey the cosmetics industry on current manufacturing practices, with 900 companies selected for invitations to participate. More cosmetics news in brief.

Beauty Regulation

Avon Joins Global #BeCrueltyFree Campaign Amid Natura Deal Talks

The turnaround-minded direct seller confirmed in late March that it was in discussions with Natura about a potential transaction. Natura prides itself on its cruelty-free status, and Avon increasingly seems like it could be a good fit in that regard.

Beauty Business Strategies

Benzoyl Peroxide Effective On Acne, But No Skin Microbiome Effect – Study

Acne treatment study found set out to better understand the pathogenesis of pre-adolescent acne and the impact of OTC acne drug benzoyl peroxide after an earlier study showed treatment with ingredient significantly decreased alpha diversity on girls' skin.

OTC Drugs Cosmetics

P&G Ups Forecast On Beauty, Health Results, Despite 'A Lot Of Variability'

P&G beauty division's sales grow on premium skin care lines and despite price increases as health care sales grow 5% on volume, particularly in oral care. Net earnings in latest quarter grow 9% to $2.78bn as results prompt investor activity with share price slipping 2.7% in trading at nearly twice average volume.

Commercial Business Strategies

L’Oreal Luxe Not Losing Steam In Asia; Consumer Biz Lifts On Garnier Momentum

The French cosmetics giant continues to benefit from Chinese millennials with voracious luxury appetites, posting 14% like-for-like growth in its Luxe division for the fiscal 2019 first quarter. L’Oreal’s Consumer Products business is improving as well, with a return to growth in Western Europe, while North America continues to struggle.

Beauty Business Strategies

Canada Moving Toward Cosmetic Animal-Testing Ban Potentially Stricter Than California Law

The Cruelty-Free Cosmetics Act, S 214, would ban the sale of cosmetics developed with animal testing that’s conducted four years or more after enactment, ostensibly including testing undertaken to comply with foreign regulations. The sole exemption is for animal testing that is Health Canada-authorized.

Canada Animal Testing
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

FDA Urged To Crack Down On Supplements For Nicotine Addiction

The Center for Science in the Public Interest urges the US Food and Drug Administration to seize products from marketers of 15 dietary supplements that claim to treat nicotine addiction. In an April 24 letter, the advocacy group says none of the marketers could present evidence in support of claims promising quick relief from addiction and/or results comparable to FDA-approved Rx and OTC drug products.

Wellness Regulation

Another 'Rhino' Marketer Horned By US FDA About ED-Spiked Supplements

Warning letter says Empire Distributors sold product branded “Rhino Black 5K Plus” that FDA analysis found contained sildenafil and tadalafil. FDA officials found on its websites, including an Amazon.com storefront, supplements bearing others brands used for products previously found with ED ingredients, including "Black Mamba Premium,” “Libigrow,” ““Rhino 25K,” and “Stamina-Rx.”

Dietary Supplements Regulation

CBD Wellness News: BoxScore Pivots To CBD, Shineco, Datong JV, More

Endo Water researches Kansas; CannAmerica new packages, gummy flavors shipping; Profile's Elite brand blooms CBD Flower; NeutriSci, Falcon plan sublingual CBD tablet; Aleafia distributed metered-dose cannabis spray; Plus launches Classic Mint, makes CFO switch; BoxScore Brands pivots to CBD focus with new CEO; and Shineco, Datong JV for hemp supplement chain, DBD development.

Dietary Supplements Commercial

Wellness Product Launches: Equelle For Menopause, Renadyl For Uremic Toxins, More

S-equol in Equelle menopause supplement; antioxidant support for PTSD symptoms; supplement targets uremic toxins; green tea for heart health; and CartiJoint with Bio-Curcumin Curcugree.

Dietary Supplements Commercial

CBD Market: Vitamin Shoppe Enters Field, More Gummies Launched

Nutrition, health and wellness productfirm launches its CBD sales with Irwin's Naturals products and also offers SpaRoom oils. Green Gorilla and Folium Biosciences are the latest nutritional product firms to offer CBD-containing supplements in gummy format.

Dietary Supplements Commercial

NPA Slams Study Linking Calcium, Vitamin D Use To Increased Cancer Risk

Annals of Medicine study finds at least 1,000mg/day calcium supplementation associated with increased risk of cancer, but no association of cancer and high levels of calcium from foods. Natural Products Association says study included an ‘unhealthy’ cohort of patients.

Wellness Analysis
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

Norway's OTC Market In 2018: Sales Remain Stable As GSK Consolidates Its Leading Position

Sales of non-prescription medicines in Norway edged up by less than 1% in 2018, as GSK remained the leading player on the market and its Otrivin respiratory line maintained its position as the country's best-selling OTC brand. 
Norway Market Intelligence

Consumers Across EU Struggling To Interpret Nutrition And Health Claims

Consumers need more support to help them accurately interpret nutrition and health claims made on foods, including food supplements, a study across five EU markets suggests. Nutrition claims and health claims are regularly confused by consumers, and their technical wording often means they are misunderstood or not understood at all.

Dietary Supplements Europe

EMA Is Exploring How Real-World Data Can Benefit Europe’s OTC Market, Says Agency Head Rasi

The European Medicines Agency is right now looking into how real-world data and evidence can be used to improve regulatory systems and extend access to OTC medicines within the European Union, the agency's executive director Guido Rasi told the recent AESGP Regulatory Conference in Amsterdam.

Regulation Europe
See All
UsernamePublicRestriction

Register

Advertisement